| Bradley Pharmaceuticals 2007 Third Quarter Results
FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, (Nachrichten) Inc. announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Third Quarter of 2007 -- Launched ADOXA(R) 150mg capsules. -- Paid outstanding principal balance of $62.4 million under old credit facility on August 3, 2007 with existing cash and cash equivalents, concurrently with entering into a new credit facility and wrote-off deferred financing costs of $3.3 million related to old facility. -- On October 29, 2007, the Company entered into a definitive merger agreement with Nycomed US Inc. Bradley reported that net sales for the quarter ended September 30, 2007 were approximately $33.6 million, a decrease of $1.6 million, or 5%, from net sales of $35.2 million for the quarter ended September 30, 2006.
Skin Care Tips From The Top
When it comes to helping patients detect skin cancer, combat acne and acne scarring, treat hair loss and nail fungus, and find a customized daily skin care regimen to maintain healthy skin, dermatologists -- physicians with extensive training and experience in treating skin, hair and nail conditions -- are the specialists to whom millions of people of all ages turn for expert care. In addition, dermatologists can advise patients looking to improve aging skin on the most appropriate over-the-counter, medical and surgical options available to them.
Speaking today at the American Academy of Dermatology's (Academy) Skin Academy, dermatologist Arielle N.B. Kauvar, MD, FAAD, chair of the Academy's Council on Communications, discussed the breadth of expertise dermatologists provide and led an open discussion with fellow dermatologists on their top skin, hair and nail tips.
Questions raised about drug being studied for MS
A group of American scientists has warned other researchers that an acne drug being tested as a possible treatment for a variety of neurodegenerative diseases - including in Canada for multiple sclerosis - may actually cause harm. The scientists reported that in a clinical trial of patients with amyotrophic lateral sclerosis or Lou Gehrig's disease, those who received the drug minocycline declined more rapidly than those who received a placebo. Their report, published Thursday in the journal Lancet Neurology, comes just a week after the Multiple Sclerosis Society of Canada announced it was funding a multi-centre Phase 3 trial to look at whether the inexpensive and off-patent minocycline can slow the progression of MS when treatment is commenced in the earliest stages of the disease.
TALKING SHOP: Lucker is Counselor of the Year
Bill Lucker, a chemical dependency counselor with the Bowen Center, has been named 2007 Drug and Alcohol Counselor of the Year by the Indiana State Counselors Association.Lucker has been serving the Huntington community through the Bowen Center for 16 years and is now serving the Grant County community as well. In addition to serving as a counselor, he is also the Bowen Center's building safety representative, building superintendent and “general problem solver."Lucker volunteers with Habitat for Humanity and is a member of College Park Church.Staff expands at Coach HouseThe Coach House Day Spa has announced the addition of three new staff members - massage therapist DaVina Walker, nail technician Kim Brown, and esthetician Kristi Brouwer. All three are accepting new clients.Walker graduated from The Alexandria School of Scientific Therapeutics.
|
